VITAMIN-K DEFICIENCY IN NEONATES
Phase 3
- Conditions
- Health Condition 1: D699- Hemorrhagic condition, unspecified
- Registration Number
- CTRI/2023/05/053148
- Lead Sponsor
- INDIRA GANDHI INSTITUTE OF CHILD HEALTH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All Neonates with gestational age of >28weeks,within 14 days of life.
Should have received birth dose of vitamin-k.
Received antibiotics for 7 days .
Informed parental consent
Willing for follow up till 4 weeks of age.
Exclusion Criteria
Neonates with major congenital malformations or life threatening diseases.
Neonatal cholestasis or any other medical conditions causing vitamin-k deficiency.
Neonates on prolonged TPN, cholestasis etc receiving prophylactic vitamin-k.
Neonates receiving vitamin-k antagonists.
Neonates born to mother who have received or currently receiving vitamin-k antagonists
,anticonvulsants or anti-TB drugs.
Neonates receiving anticonvulsants or anti-TB.
Neonates with acute kidney injury (serum creatinine >1.5mg/dl).
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method